FDA Sticks Breakthrough Tag on GlaxoSmithKline's Blood Cancer Drug Post author:Sam Post published:November 1, 2017 Post category:BioPharma GSK2857916 is an anti B-cell maturation agent (BCMA) monoclonal antibody-drug conjugate. Source: BioSpace You Might Also Like Longtime CEO at Bay Area's OncoMed Steps Down January 4, 2018 <b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017 Gamida Cell Taps Former Clal Biotech CSO as New Leader November 19, 2017
<b>Mapi Research Trust</b> Appointed As Exclusive Distributor And Mapi Language Services As Exclusive Translator Of The "Disease Activity Score (DAS-28)" July 6, 2017
